US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

261.85

-0.4300-0.16%

Post-market: 261.850.00000.00%19:30 EDT

Volume:30.06K

Turnover:7.90M

Market Cap:2.84B

PE:30.64

High:264.97

Open:264.46

Low:261.85

Close:262.28

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.98

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.02

PE(LYR):6.94

Loading ...

Overview Company News Filings

Bruker Nano President Mark Munch Sells 2,000 Bruker Shares Worth $120,500

Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma

Neo Performance Materials Inc (NEO) Gets a Buy from Stifel Nicolaus

Ernexa Therapeutics announces new ERNA-101 preclinical data

Bruker Acquires Noscendo’s Disqver Metagenomic Sequencing Platform

Bruker Corp - Disqver Acquisition not Expected to be Material to Bruker FY26 Results

THOMSON REUTERS

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic Mngs Disqver® Platform for Pathogenic Microorganisms in Blood

THOMSON REUTERS

Bruker Corp: Financial Details of Transaction were not Disclosed

THOMSON REUTERS

Bruker Corp : TD Cowen Raises Target Price to $60 from $45

THOMSON REUTERS

Veracyte Inc : Piper Sandler Initiates Coverage with Overweight Rating; Price Target $66

THOMSON REUTERS

Alkermes Schedules Second-quarter Results Call and Webcast

Alkermes to Report Second Quarter Financial Results on July 28, 2026

THOMSON REUTERS

Veracyte is Maintained at Hold by Canaccord Genuity

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

Simply Wall St.

Voyager Therapeutics advances tau-silencing gene therapy program

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS

Alkermes Price Target Announced at $60.00/share by JP Morgan

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/FBT/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":261.85,"timestamp":1789156800000,"preClose":262.28,"halted":0,"volume":30061,"hourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0016394692694828047,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Market Closed","change":-0.43,"latestTime":"09-11 16:00:00 EDT","open":264.46,"high":264.965,"low":261.85,"amount":7900544.843099999,"amplitude":0.011877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":262.28,"sharesOutstanding":11450002,"nav":262.39,"aum":2860051524.78,"bidAskSpread":0.001063,"preHourTrading":{"tag":"盘前","latestPrice":262.28,"preClose":262.28,"latestTime":"08:18 EDT","volume":1,"amount":262.28,"timestamp":1789129101219,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9828931233249508,"impliedVol":0.2371,"impliedVolPercentile":0.8725},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.9828931233249508,"shares":10850002,"dividePrice":0,"high":264.965,"amplitude":0.011877,"preClose":262.28,"low":261.85,"week52Low":173.975,"pbRate":"1.02","psRate":"685.38","week52High":274.99,"institutionHeld":0,"latestPrice":261.85,"eps":8.545272,"divideRate":0,"volume":30061,"delay":0,"ttmEps":8.545272,"open":264.46,"prevYearClose":206.52,"prevWeekClose":270.93,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":273.79,"twentyDayClose":256.07,"sixtyDayClose":226.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652424061","title":"Bruker Nano President Mark Munch Sells 2,000 Bruker Shares Worth $120,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2652424061","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652424061?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:15","pubTimestamp":1784232946,"startTime":"0","endTime":"0","summary":"Bruker Nano President Mark Munch sells 2,000 Bruker shares worth $120,500Bruker Nano Executive VP and President Mark Munch exercised stock options for 2,000 shares at USD 22.19 on July 15, 2026.Munch ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL96mhtV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bruker Nano President Mark Munch Sells 2,000 Bruker Shares Worth $120,500","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","LU0757428866.USD","BRKR","BK4121","TINY","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425738","title":"Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425738?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219512,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The long term follow up study of AAVAnc80-antiVEGF gene therapy a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-backed-gene-therapy-study-tracks-long-term-safety-in-vestibular-schwannoma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-backed-gene-therapy-study-tracks-long-term-safety-in-vestibular-schwannoma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","FBT","BK4588","BK4585","IBB","SYNB","GNOM","IBBQ","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410274","title":"Neo Performance Materials Inc (NEO) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651410274?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:16","pubTimestamp":1784204211,"startTime":"0","endTime":"0","summary":"In a report released today, Ian Gillies from Stifel Nicolaus maintained a Buy rating on Neo Performance Materials Inc, with a price target of C$49....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neo-performance-materials-inc-neo-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neo-performance-materials-inc-neo-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NEO","BK4121","LU0106261612.USD","BK4127","LU0012050646.USD","SF","FBT","BK4196","UYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651646874","title":"Ernexa Therapeutics announces new ERNA-101 preclinical data","url":"https://stock-news.laohu8.com/highlight/detail?id=2651646874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651646874?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:15","pubTimestamp":1784117721,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) announced new preclinical data independently validating the anti-tumor activity of its lead cell therapy candidate, ERNA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-announces-new-erna-101-preclinical-data-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BK4588","IBB","BK4585","CNCR","LFSC","FBT","SYNB","ERNA","GNOM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651747452","title":"Bruker Acquires Noscendo’s Disqver Metagenomic Sequencing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2651747452","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651747452?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:01","pubTimestamp":1784113262,"startTime":"0","endTime":"0","summary":"Bruker acquires Noscendo’s DISQVER metagenomic sequencing platformBruker acquired the DISQVER clinical metagenomics platform from Noscendo, expanding its NGS-based infection detection portfolio.DISQVE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLhPZ2l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TINY","BK4121","LU0757428866.USD","LU1815336091.USD","FBT","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651645222","title":"Bruker Corp - Disqver Acquisition not Expected to be Material to Bruker FY26 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2651645222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651645222?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA9YPR6T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BRKR","LU1815336091.USD","TINY","FBT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452278","title":"Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic Mngs Disqver® Platform for Pathogenic Microorganisms in Blood","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452278?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA9YPR6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","LU0757428866.USD","BRKR","FBT","LU1815336091.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651045222","title":"Bruker Corp: Financial Details of Transaction were not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2651045222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651045222?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA9YPR6T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4121","BRKR","LU1815336091.USD","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651518034","title":"Bruker Corp : TD Cowen Raises Target Price to $60 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2651518034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651518034?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:57","pubTimestamp":1784109461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","BK4121","LU0757428866.USD","LU1815336091.USD","FBT","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651458340","title":"Veracyte Inc : Piper Sandler Initiates Coverage with Overweight Rating; Price Target $66","url":"https://stock-news.laohu8.com/highlight/detail?id=2651458340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651458340?lang=en_us&edition=fundamental","pubTime":"2026-07-15 15:44","pubTimestamp":1784101462,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651948609","title":"Alkermes Schedules Second-quarter Results Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2651948609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651948609?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:00","pubTimestamp":1784059224,"startTime":"0","endTime":"0","summary":"Alkermes schedules second-quarter results call and webcastAlkermes schedules a conference call and webcast at 8 a.m. ET on July 28, 2026 to discuss second-quarter financial results.Webcast player and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL4ZHnfJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PSCH","IBRN","ALKS","BK4139","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651248620","title":"Alkermes to Report Second Quarter Financial Results on July 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651248620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651248620?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:00","pubTimestamp":1784059200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA9LS4JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","IBRN","BK4139","ALKS","FBT","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651034451","title":"Veracyte is Maintained at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2651034451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651034451?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:13","pubTimestamp":1784031180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VCYT/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:13 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651430120","title":"Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651430120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651430120?lang=en_us&edition=fundamental","pubTime":"2026-07-14 14:29","pubTimestamp":1784010575,"startTime":"0","endTime":"0","summary":"In July 2026, NeoGenomics, Inc. launched PTEN IHC CDx, the first FDA-approved immunohistochemistry companion diagnostic for prostate adenocarcinoma, enabling identification of PTEN-deficient tumors in patients who may be eligible for AstraZeneca’s TRUQAP (capivasertib), with testing available across its national oncology laboratory network.\nThis test not only extends NeoGenomics’ presence into urologic oncology but also deepens its role in personalized prostate cancer care through rapid,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/does-neogenomics-neo-new-pten-cdx-move-reveal-a-deeper-preci","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/does-neogenomics-neo-new-pten-cdx-move-reveal-a-deeper-preci","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4092","BK4196","LU0106261612.USD","PTEN","BK4121","NEO","LU0012050646.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145087","title":"Voyager Therapeutics advances tau-silencing gene therapy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145087","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145087?lang=en_us&edition=fundamental","pubTime":"2026-07-14 01:27","pubTimestamp":1783963636,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics ( ($VYGR) ) has provided an update. On July 13, 2026, Voyager Therapeutics presented three- and six-month good laboratory prac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/voyager-therapeutics-advances-tau-silencing-gene-therapy-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","LFSC","IBBQ","IBB","BK4585","FBT","BK4139","SYNB","GNOM","VYGR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143954","title":"Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143954?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:10","pubTimestamp":1783959019,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alkermes-alks-transmedics-group-tmdx-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","LU0320765992.SGD","IE0009355771.USD","LU0109394709.USD","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","HCSG","ALKS","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4585","LU2324357040.USD","MEDX","BK4581","PSIL","FBT","IBRN","LU0029874061.USD","BK4137","TMDX","PRAX","XLV","BK4588","XBI","LU0128526141.USD","PSCH","BK4082","IE00BJJMRZ35.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128211","title":"Alkermes Plc : TD Cowen Raises Target Price to $57 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651128211?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:29","pubTimestamp":1783949398,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","IBRN","ALKS","MEDX","BK4139","PSIL","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115701","title":"Alkermes Price Target Announced at $60.00/share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115701?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:10","pubTimestamp":1783941000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 07:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","PSIL","PSCH","BK4139","IBRN","ALKS","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115250","title":"Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115250?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:01","pubTimestamp":1783940468,"startTime":"0","endTime":"0","summary":"Alkermes says alixorexton sustains wakefulness gains in nine-month narcolepsy extension study interim analysisAlkermes reported interim long-term extension results showing alixorexton sustained clinic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL7r2w61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","ALKS","IBRN","PSIL","PSCH","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651904115","title":"Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested","url":"https://stock-news.laohu8.com/highlight/detail?id=2651904115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651904115?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:00","pubTimestamp":1783940428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43D02G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","ALKS","IBRN","PSCH","BK4139","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}